Celecoxib
Celecoxib is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Celecoxib; Generic name: CELECOXIB; Drug class: Nonsteroidal Anti-inflammatory Drug [EPC].
| Brand name | Celecoxib |
|---|---|
| Generic name | CELECOXIB |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Manufacturer | Alembic Pharmaceuticals Limited |
| Used for | 1 INDICATIONS AND USAGE Carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see Warnings and Precautions (5) ] Celecoxib is a non steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) (1.1) Rheumatoid Arthritis (RA) (1.2) Juvenile Rheumatoid Arthritis (JRA) in patients 2 years and older(1.3) Ankylosing Spondylitis (AS) (1.4) Acute Pain (AP) (1.5) Primary Dysmenorrhea (PD) (1.6) 1.1 Osteoarthritis (OA) Celecoxib is indicated for relief of the signs and symptoms of OA [ see Clinical Studies (14.1) ] |
| Dosage | 2 DOSAGE AND ADMINISTRATION Use lowest effective dose for the shortest duration consistent with treatment goals for the individual patient. These doses can be given without regard to timing of meals. Use lowest effective dose for the shortest duration consistent with treatment goals for the individual patient. (1,5.1,5.4) OA : 200 mg once daily or 100 mg twice daily (2.1,14.1) RA : 100 to 200 mg twice daily (2.2,14.2) JRA : 50 mg twice daily in patients 10 to 25 kg. 100 mg twice daily in patient |
| Warnings | WARNING: CARDIOVASCULAR AND GASTROINTESTINAL RISKS Cardiovascular Risk Celecoxib may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. All nonsteroidal anti-inflammatory drugs (NSAIDs) may have a similar risk. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk (5.1, 14.6) . Celecoxib is contraindicated for the treatment of peri |
| Active ingredient(s) | CELECOXIB |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14e8d788-e44c-4a40-8678-25cf45fed477 |